![](/images/2013/post-sep.jpg)
Sleep Specialists Celebrates 15 Years, Unveils Zzoma+ Sensor, Launches Clinical Trial, Focuses on Value-Based Care
HOUSTON, TEXAS, UNITED STATES, June 3, 2024 /EINPresswire.com/ -- Sleep Specialists, a leader in FDA-cleared medical devices for the treatment of mild to moderate sleep apnea, celebrates its 15th anniversary with a series of advancements underscoring its commitment to innovation and patient-centered care. This includes the unveiling of Zzoma Plus, a groundbreaking clinical trial, and a new subsidiary dedicated to value-based healthcare solutions.
๐๐๐ญ ๐ ๐ ๐ข๐ซ๐ฌ๐ญ ๐๐จ๐จ๐ค ๐๐ญ ๐๐ณ๐จ๐ฆ๐'๐ฌ ๐๐๐ฏ๐๐ง๐๐๐ฆ๐๐ง๐ญ๐ฌ ๐๐ญ ๐๐๐๐ ๐๐๐๐
Sleep Specialists will be showcasing all these exciting developments at the upcoming American Academy of Sleep Medicine (AASM) Conference in Houston, Texas, from June 3rd to June 5th. Visit us at Booth 504 to:
โ Experience Zzoma Plus, the next generation positional and adherence sensor.
โ Learn about our clinical trial comparing Zzoma with traditional CPAP therapy for cardiovascular risk.
โ Discover our partnership with SleepScore and how the companion app empowers patients.
โ Explore our focus on value-based care in sleep medicine.
๐๐ณ๐จ๐ฆ๐ ๐๐ฅ๐ฎ๐ฌ: ๐๐๐ค๐ข๐ง๐ ๐๐ฅ๐๐๐ฉ ๐๐๐ง๐๐ ๐๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐ญ๐ก๐ ๐๐๐ฑ๐ญ ๐๐๐ฏ๐๐ฅ
Building upon the success of the original device, Zzoma Plus introduces advanced patient adherence tracking and enhanced clinical efficacy data collection. These improvements will help physicians optimize treatment, ensuring the best possible results for their patients.
โZzoma Plus represents the next step in our journey. Weโre leveraging insights from 15 years of clinical use with cutting-edge technology to empower physicians and patients with more personalized and effective solutions.โ
๐๐ณ๐จ๐ฆ๐ + ๐๐ฅ๐๐๐ฉ๐๐๐จ๐ซ๐: ๐ ๐๐จ๐ฆ๐ฉ๐ซ๐๐ก๐๐ง๐ฌ๐ข๐ฏ๐ ๐๐ฅ๐๐๐ฉ ๐๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง
Sleep Specialists is also announcing a partnership with SleepScore to offer the clinically-validated SleepScore companion app alongside Zzoma therapy. This comprehensive system empowers patients to track their progress, stay motivated, and experience the full benefits of improved sleep health.
๐๐ฅ๐ข๐ง๐ข๐๐๐ฅ ๐๐ซ๐ข๐๐ฅ: ๐๐ณ๐จ๐ฆ๐ ๐ฏ๐ฌ. ๐๐๐๐
Sleep Specialists is launching a major clinical trial comparing the use of Zzoma Positional Therapy to CPAP on Cardiovascular Dysfunction in Sleep Apnea. This research underscores Zzoma's commitment to advancing sleep solutions and offering physicians and patients data-driven treatment choices.
๐๐๐จ๐ฎ๐ญ ๐๐ฅ๐๐๐ฉ ๐๐ฉ๐๐๐ข๐๐ฅ๐ข๐ฌ๐ญ๐ฌ, ๐๐๐
Sleep Specialists, LLC is a rapidly growing medical device and services company dedicated to developing innovative solutions for sleep-related disorders. Their flagship product, Zzoma, is a clinically proven, FDA-cleared positional therapy device for Positional Obstructive Sleep Apnea (OSA). Sleep Specialists is experiencing substantial momentum, marked by:
โ Strategic partnership with First Nation, expanding access to Zzoma in government hospitals.
โ Investment in US manufacturing, ensuring product availability and domestic production.
โ Over 1,800 physicians and 1,300 sleep centers prescribing Zzoma, demonstrating growing recognition of its value in treating OSA patients.
๐๐จ๐ญ๐: Zzoma Plus is currently under development and has not yet received FDA clearance.
ZZOMA
Sleep Specialist, LLC
+1 877-799-9662
info@zzomaosa.com
Visit us on social media:
Facebook
X
LinkedIn
Instagram
YouTube
![](https://adb.einnews.com/tracking/article.gif?aid=716791481§ion=einpresswire&a=-6mBkiaRkNEtZNug&i=yFKtoc91fX2L0kVm)
Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations, Media, Advertising & PR, Sports, Fitness & Recreation, Technology
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release